Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

KALEIDO BIOSCIENCES, INC.

(KLDO)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op KALEIDO BIOSCIENCES, INC.
06/12Kaleido Biosciences Expands and Extends Collaboration With Janssen
06/12Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potent..
15/11Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ..
10/11Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
10/11Kaleido Biosciences, Inc. to Appoint Alison Long as Chief Medical Officer, Effective De..
01/11KALEIDO BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition ..
01/11Press Release issued by Kaleido Biosciences, Inc., dated November 1, 2021, furnished he..
01/11Kaleido Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Month..
01/11Kaleido Biosciences Reports Third Quarter 2021 Financial Results
20/10NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
12/10KALEIDO BIOSCIENCES : to Participate in the Jefferies Virtual Next Generation IBD Therapeu..
05/10KALEIDO BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
05/10KALEIDO BIOSCIENCES : Says Bowel Disease Drug Trial Meets Primary Safety Endpoint
05/10KALEIDO BIOSCIENCES : Announces New Clinical and Preclinical Data Supporting Advancement o..
05/10Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement ..
29/09Kaleido Biosciences to Host Virtual R&D Presentation to Discuss Clinical Data and Pipel..
29/09Kaleido Biosciences, Inc. to Host Virtual R&D Presentation to Discuss Clinical Data and..
20/09KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to S&P Global BMI Index
03/09KALEIDO BIOSCIENCES, INC. : Other Events (form 8-K)
03/09Kaleido Biosciences, Inc. Receives Warning Letter from the U.S. Food and Drug Administr..
02/09Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Hea..
11/08KALEIDO BIOSCIENCES : Press Release issued by Kaleido Biosciences, Inc., dated August 11, ..
11/08KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
11/08Kaleido Biosciences Reports Second Quarter 2021 Financial Results
11/08Kaleido Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Sec..
10/08KALEIDO BIOSCIENCES : Teams Up With COPD Foundation to Advance KB109 into Phase 2a Clinica..
10/08KALEIDO BIOSCIENCES : and the COPD Foundation Announce a Strategic Collaboration to Advanc..
10/08Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advan..
09/08KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement..
09/08KALEIDO BIOSCIENCES : Announces New Chairperson Appointment to its Board of Directors
09/08Kaleido Biosciences, Inc. Announces Appointment of Theo Melas-Kyriazi as Chairperson of..
06/08KALEIDO BIOSCIENCES : to Participate in the 41st Annual Canaccord Genuity Growth Conferenc..
02/07KALEIDO BIOSCIENCES : Appoints Jerald Korn Chief Operating Officer
02/07KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
02/07Kaleido Biosciences, Inc. Appoints Jerald Korn as Chief Operating Officer
25/06KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell Small Cap Comp Value Index
25/06KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell Microcap Value Index
25/06KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 3000 Value Index
25/06KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 3000E Value Index
25/06KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 2500 Value Index
25/06KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 2000 Value Index
17/06KALEIDO BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Other Eve..
10/06Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
05/05Certain Stock Options of Kaleido Biosciences, Inc. are subject to a Lock-Up Agreement E..
05/05Certain Restricted Stock Units of Kaleido Biosciences, Inc. are subject to a Lock-Up Ag..
05/05Certain Common Stock of Kaleido Biosciences, Inc. are subject to a Lock-Up Agreement En..
04/05KALEIDO BIOSCIENCES' : Q1 Loss Narrows; Expects Enough Funds to Operate Into Q1 2022
04/05KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
04/05Kaleido Biosciences Reports First Quarter 2021 Financial Results
04/05Kaleido Biosciences, Inc. and Cadena Bio, Inc. Enter into Third Amendment to Loan and S..
04/05Kaleido Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Fir..
21/04KALEIDO BIOSCIENCES : Announces Collaboration with Robert Jenq, M.D., to Explore Potential..
20/04KALEIDO BIOSCIENCES : to Collaborate with MD Anderson Cancer Center Expert on Microbiome T..
20/04Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potentia..
20/04Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potentia..
15/04Kaleido Biosciences to Participate in Jefferies Microbiome-Based Therapeutics Summit
25/03KALEIDO BIOSCIENCES : Reports Positive Results from Non-IND Study
24/03SECTOR UPDATE : Health Care Stocks Climb Premarket Wednesday
24/03KALEIDO BIOSCIENCES : Reports Positive Results From KB109 Study to Treat COVID-19; Shares ..
24/03KALEIDO BIOSCIENCES, INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
24/03Kaleido Biosciences Reports Positive Results from Non-IND Study Demonstrating a Reducti..
24/03Kaleido Biosciences, Inc. Reports Positive Results from Non-IND Study Demonstrating a R..
09/03AGILENT TECHNOLOGIES : Brings in Former Kaleido Biosciences Exec as Chief Medical Officer
04/03KALEIDO BIOSCIENCES : Share Dilution Drives Price Target Cut at Chardan
03/03KALEIDO BIOSCIENCES : Posts Narrower Q4 Loss
03/03Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
03/03Kaleido Biosciences, Inc. Reports Unaudited Consolidated Earnings Results for the Fourt..
03/03KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
03/03Kaleido Biosciences, Inc. Auditor Raises 'Going Concern' Doubt
02/03KALEIDO BIOSCIENCES : to Present at Chardan's 3rd Annual Microbiome Medicines Summit
01/03Kaleido Biosciences to Present at Chardan's 3rd†Annual Microbiome Medicines Summit
11/02Kaleido Biosciences Announces the Exercise of the Underwriters' Option to Purchase Addi..
08/02KALEIDO BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events (form..
04/02Kaleido Biosciences Announces Pricing of Public Offering of Common Stock
03/02Kaleido Biosciences Announces Proposed Public Offering of Common Stock
1  2  3Volgende
Volgende evenement op KALEIDO BIOSCIENCES, INC.
07/03/22